This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07400/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07400/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07400/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07400/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07400/identifier/pdb/

Statements

Subject Item
n2:DB07400
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07400 n7:DB07400
dcterms:title
1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE
adms:identifier
n9:392213 n10:444224 n11:99443871 n12:DB07400 n13:AZL
n3:IUPAC-Name
n4:271B40A8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B40AE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B40AD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B40AA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B40AB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B40AC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B40A6-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B40A7-363D-11E5-9242-09173F13E4C5 n4:271B40A4-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B40A5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B40B4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B40B5-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B40AF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B40B0-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B40B2-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B40B1-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B40B3-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B40BA-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B40BC-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B40BD-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B40B9-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B40B8-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B40BB-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B40A9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B40B6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B40B7-363D-11E5-9242-09173F13E4C5